This can include dysfunction of natural killer (NK) cells and macrophages that decrease the anti-EGFR antibody-dependent cellular cytotoxicity, and decreased density of effector T-cells and increased PD-L1 expression which assist cancer survival. This evidence concerns the gene EGFR and cancer.